Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Michael B. Chancellor(18.8%)
Lipella Pharmaceuticals | D:发行公告
Lipella Pharmaceuticals | 10-Q:2024财年二季报
Lipella Pharmaceuticals | ARS:年度报告
Lipella Pharmaceuticals | DEF 14A:股东委托书决议
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 424B5:募资说明书
Lipella Pharmaceuticals | PRE 14A:并购重组委托声明
Lipella Pharmaceuticals | 4:持股变动声明-高管 Kaufman Jonathan H
Lipella Pharmaceuticals | 10-Q:2024财年一季报
Lipella Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Jonathan H. Kaufman(19.3%)
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 4:持股变动声明-董事 Pruchnic Ryan
Lipella Pharmaceuticals | 4:持股变动声明-董事 Yoshimura Naoki
Lipella Pharmaceuticals | 4:持股变动声明-高管 Chancellor Michael B
Lipella Pharmaceuticals | 4:持股变动声明-董事 Birder Lori
Lipella Pharmaceuticals | 4:持股变动声明-高管 Kaufman Jonathan H
暂无数据